United Therapeutics | UTHR - Deudores Comerciales





Deudores Comerciales Cambio Fecha
Amarin USD 126.83M 477K 2025-12
Ardelyx USD 71.85M 4.76M 2025-12
Baxter International USD 1.7B 310M 2026-03
Bayer EUR 18.55B 4.36B 2026-03
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Gilead Sciences USD 4.74B 172M 2026-03
GlaxoSmithKline GBP 7.94B 178M 2026-03
Halozyme Therapeutics USD 457.99M 16.72M 2026-03
Insmed USD 178.55M 37.7M 2026-03
Ionis Pharmaceuticals USD 74M 8M 2026-03
J&J USD 21.33B 3.72B 2025-12
Lexicon Pharmaceuticals USD 2.38M 50K 2025-12
Moderna USD 71M 113M 2026-03
Omeros USD 8.08M 440K 2024-06
Pfizer USD 16.17B 332M 2026-03
PTC Therapeutics USD 181.62M 21.45M 2025-12
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Sangamo BioSciences USD 581K 110K 2024-06
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Teva Pharmaceutical Industries USD 3.39B 316M 2026-03
United Therapeutics USD 312M 38.2M 2026-03
Vertex Pharmaceuticals USD 2B 56.7M 2026-03